These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11152294)

  • 41. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
    Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
    J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent antidiuretic agonists, deamino-vasopressin and desmopressin, and their inverso analogs: NMR structure and interactions with micellar and liposomic models of cell membrane.
    Lubecka EA; Sikorska E; Sobolewski D; Prahl A; Slaninová J; Ciarkowski J
    Biopolymers; 2016 May; 106(3):245-59. PubMed ID: 26916937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NMR studies of new arginine vasopressin analogs modified with alpha-2-indanylglycine enantiomers at position 2 bound to sodium dodecyl sulfate micelles.
    Lubecka E; Kwiatkowska A; Ciarkowski J; Sikorska E
    Biophys Chem; 2010 Oct; 151(3):139-48. PubMed ID: 20598431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
    Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
    Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
    Mattern RH; Tran TA; Goodman M
    J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
    Lempicka E; Slaninova J; Olma A; Lammek B
    J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arginine-, D-arginine-vasopressin, and their inverso analogues in micellar and liposomic models of cell membrane: CD, NMR, and molecular dynamics studies.
    Lubecka EA; Sikorska E; Sobolewski D; Prahl A; Slaninová J; Ciarkowski J
    Eur Biophys J; 2015 Dec; 44(8):727-43. PubMed ID: 26290060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery and design of novel vasopressin hypotensive peptide agonists.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Recept Signal Transduct Res; 1999; 19(1-4):631-44. PubMed ID: 10071789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe.
    Arsenijevic Y; Dubois-Dauphin M; Tribollet E; Manning M; Sawyer WH; Dreifuss JJ
    J Endocrinol; 1994 Jun; 141(3):383-91. PubMed ID: 8071638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes.
    Torres BA; Johnson HM
    J Immunol; 1988 Apr; 140(7):2179-83. PubMed ID: 2965181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor.
    Howl J; Wang X; Kirk CJ; Wheatley M
    Eur J Biochem; 1993 Apr; 213(2):711-9. PubMed ID: 8477743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational transformation of ascidiacyclamide analogues induced by incorporating enantiomers of phenylalanine, 1-naphthylalanine or 2-naphthylalanine.
    Asano A; Minoura K; Yamada T; Doi M
    J Pept Sci; 2016 Mar; 22(3):156-65. PubMed ID: 26856689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
    Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation.
    Schmidt JM; Ohlenschläger O; Rüterjans H; Grzonka Z; Kojro E; Pavo I; Fahrenholz F
    Eur J Biochem; 1991 Oct; 201(2):355-71. PubMed ID: 1935933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.